Morgan Stanley Cellebrite Di Ltd. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Morgan Stanley holds 4,652,578 shares of CLBT stock, worth $78.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,652,578
Previous 3,963,259
17.39%
Holding current value
$78.2 Million
Previous $77 Million
3.33%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding CLBT
# of Institutions
216Shares Held
99.2MCall Options Held
122KPut Options Held
80.8K-
True Wind Capital Management, L.P.13.9MShares$233 Million93.81% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.52MShares$110 Million0.07% of portfolio
-
Voss Capital, LLC Houston, TX5.15MShares$86.5 Million6.92% of portfolio
-
Invesco Ltd. Atlanta, GA3.51MShares$58.9 Million0.01% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.34MShares$56.2 Million0.67% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.19B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...